HKSE - Delayed Quote HKD

Giant Biogene Holding Co., Ltd. (2367.HK)

Compare
52.950
-0.350
(-0.66%)
At close: 4:08:14 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,524,143.000
3,524,143.000
2,364,445.000
1,552,486.000
1,190,479.000
Cost of Revenue
577,006.000
577,006.000
369,205.000
198,149.000
183,409.000
Gross Profit
2,947,137.000
2,947,137.000
1,995,240.000
1,354,337.000
1,007,069.000
Operating Expense
1,282,264.000
1,282,264.000
816,615.000
422,669.000
195,659.000
Operating Income
1,664,873.000
1,664,873.000
1,178,625.000
931,668.000
811,410.000
Net Non Operating Interest Income Expense
47,379.000
47,379.000
13,138.000
9,408.000
9,882.000
Pretax Income
1,745,089.000
1,745,089.000
1,177,749.000
972,917.000
973,242.000
Tax Provision
296,887.000
296,887.000
176,163.000
144,785.000
146,757.000
Net Income Common Stockholders
1,451,753.000
1,451,753.000
1,002,025.000
828,132.000
826,450.000
Diluted NI Available to Com Stockholders
1,451,753.000
1,451,753.000
1,002,025.000
828,132.000
826,450.000
Basic EPS
1.49
1.49
0.99
0.84
0.83
Diluted EPS
1.48
1.48
0.98
0.84
0.83
Basic Average Shares
976,278.058
976,278.058
703,129.563
991,608.800
991,608.800
Diluted Average Shares
982,716.915
982,716.915
1,021,214.617
991,608.800
991,608.800
Total Expenses
1,859,270.000
1,859,270.000
1,185,820.000
620,818.000
379,068.000
Net Income from Continuing & Discontinued Operation
1,451,753.000
1,451,753.000
1,002,025.000
828,132.000
826,450.000
Normalized Income
1,426,832.748
1,426,832.748
1,009,589.521
816,089.440
692,938.807
Interest Income
47,491.000
47,491.000
13,159.000
9,408.000
9,882.000
Interest Expense
112.000
112.000
21.000
--
--
Net Interest Income
47,379.000
47,379.000
13,138.000
9,408.000
9,882.000
EBIT
1,745,201.000
1,745,201.000
1,177,770.000
972,917.000
811,410.000
EBITDA
1,779,376.000
1,779,376.000
1,205,398.000
997,127.000
833,701.000
Reconciled Cost of Revenue
577,006.000
577,006.000
369,205.000
198,149.000
183,409.000
Reconciled Depreciation
34,175.000
34,175.000
27,628.000
24,210.000
22,291.000
Net Income from Continuing Operation Net Minority Interest
1,451,753.000
1,451,753.000
1,002,025.000
828,132.000
826,450.000
Total Unusual Items Excluding Goodwill
30,029.000
30,029.000
-8,895.000
14,148.000
157,257.000
Total Unusual Items
30,029.000
30,029.000
-8,895.000
14,148.000
157,257.000
Normalized EBITDA
1,749,347.000
1,749,347.000
1,214,293.000
982,979.000
676,444.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
5,108.748
5,108.748
-1,330.479
2,105.440
23,745.807
12/31/2020 - 11/4/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers